Difference between revisions of "Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
 
 
Line 1: Line 1:
 
{{infobox_publicationsection}}
 
{{infobox_publicationsection}}
−
<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)<br> https://doi.org/10.1080/22221751.2020.1735265<br><h3><u>Section 3.1: Screening criteria </u></h3><b><em>Go to [[Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b><p>Epidemiological history: History of travel or residence in Hubei province within 2 weeks prior to the onset of illness, or contact with patients from Hubei province with fever and respiratory symptoms within 14 days prior to onset, or presented with clustering onset.</p><p>Acute onset of fever within 72 h without influenza-like symptoms, which could not attribute to other confirmed etiology.</p><small><b><em>Go to [[Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b></small>
+
<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)<br> https://doi.org/10.1080/22221751.2020.1735265<br><h3><u>Section 3.1: Screening criteria </u></h3><p>Epidemiological history: History of travel or residence in Hubei province within 2 weeks prior to the onset of illness, or contact with patients from Hubei province with fever and respiratory symptoms within 14 days prior to onset, or presented with clustering onset.</p><p>Acute onset of fever within 72 h without influenza-like symptoms, which could not attribute to other confirmed etiology.</p><small><b><em>Go to [[Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b></small>

Latest revision as of 19:20, 14 May 2020


Navigation
ArticleDiagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265)
Sections in this Publication
SectionSection 1: Introduction (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265)
Named Entities in this Section

From publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)
https://doi.org/10.1080/22221751.2020.1735265

Section 3.1: Screening criteria

Epidemiological history: History of travel or residence in Hubei province within 2 weeks prior to the onset of illness, or contact with patients from Hubei province with fever and respiratory symptoms within 14 days prior to onset, or presented with clustering onset.

Acute onset of fever within 72 h without influenza-like symptoms, which could not attribute to other confirmed etiology.

Go to next section in publication

Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Section_3.1:_Screening_criteria_(from_DOI:_10.1080/22221751.2020.1735265)&oldid=193779"